NCT06847178: Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes
- State
- Not started
- Phase
- Phase 2 and Phase 3
- People
- 60 planned
- Started
- 1 Mar 2025
- Primary completion
- 31 Oct 2025
- Arms
- high-dose LC-Z300-01
- Results
- None posted
- 26 Feb 2025: Trial registered